Hyun Cho
Research Subjects
Hyun Cho has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Seonwoo Kim
Academic Research Service Headquarter, LSK Global PS, Seoul, Korea
3 shared publications - Jeongmin Song
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Ji Young Lee
Department of Pediatrics, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea
2 shared publications - Jihyun Kim
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea
2 shared publications - Kangmo Ahn
Department of Pediatrics, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea
2 shared publications - Minji Kim
Department of Pediatrics, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea
2 shared publications
Latest Publications
- Open Access
- 2 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6209
Comparative Efficacy and Safety of Stillen® and Rebamipide in Patients with Acute or Chronic Gastritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Background: Erosive gastritis has various causes, and severe damage to the mucosa can cause symptoms such as indigestion, abdominal pain, nausea, and vomiting. The condition is defined by visible erosions that emerge as discrete defects in the gastric mucosa. Stillen® is a natural mucosal-protective agent derived from Artemisia asiatica, but its comparative efficacy versus rebamipide remains unclear. This systematic review and network meta-analysis evaluated whether Stillen® leads to non-inferior endoscopic improvement outcomes compared to rebamipide in patients with acute or chronic gastritis. Methods: Databases including PubMed, EMBASE, Cochrane Library, RISS, KoreaMed, ClinicalTrials.gov, and ICTRP were searched through 15 August 2025. Eligible studies were randomized controlled trials (RCTs) comparing Stillen® with rebamipide or other mucosal-protective agents in gastritis. Two reviewers independently screened studies, extracted data, and evaluated the risk of bias. The primary outcome was the improvement rate (≥50% erosion reduction); the secondary outcome was the cure rate (complete erosion resolution) and safety outcomes. Results: A total of 11 RCTs met the inclusion criteria, with 9 contributing to the primary network analysis. Stillen® was non-inferior to rebamipide in terms of the improvement rate at 2 weeks (OR: 1.11, 95% CI: (0.88, 1.39) in FAS) and in pooled analysis across 2, 3, and 4 weeks. Cure rates showed no significant differences between the two agents. The safety outcomes were comparable, with no significant differences. Most studies were assessed as having a low risk of bias, and the certainty of evidence was rated as high for most efficacy outcomes. Conclusions: The network meta-analysis suggests that Stillen® is non-inferior to rebamipide in improving erosions in patients with acute or chronic gastritis.
- 2 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6209
Open AccessComparative Efficacy and Safety of Stillen® and Rebamipide in Patients with Acute or Chronic Gastritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Background: Erosive gastritis has various causes, and severe damage to the mucosa can cause symptoms such as indigestion, abdominal pain, nausea, and vomiting. The condition is defined by visible erosions that emerge as discrete defects in the gastric mucosa. Stillen® is a natural mucosal-protective agent derived from Artemisia asiatica, but its comparative efficacy versus rebamipide remains unclear. This systematic review and network meta-analysis evaluated whether Stillen® leads to non-inferior endoscopic improvement outcomes compared to rebamipide in patients with acute or chronic gastritis. Methods: Databases including PubMed, EMBASE, Cochrane Library, RISS, KoreaMed, ClinicalTrials.gov, and ICTRP were searched through 15 August 2025. Eligible studies were randomized controlled trials (RCTs) comparing Stillen® with rebamipide or other mucosal-protective agents in gastritis. Two reviewers independently screened studies, extracted data, and evaluated the risk of bias. The primary outcome was the improvement rate (≥50% erosion reduction); the secondary outcome was the cure rate (complete erosion resolution) and safety outcomes. Results: A total of 11 RCTs met the inclusion criteria, with 9 contributing to the primary network analysis. Stillen® was non-inferior to rebamipide in terms of the improvement rate at 2 weeks (OR: 1.11, 95% CI: (0.88, 1.39) in FAS) and in pooled analysis across 2, 3, and 4 weeks. Cure rates showed no significant differences between the two agents. The safety outcomes were comparable, with no significant differences. Most studies were assessed as having a low risk of bias, and the certainty of evidence was rated as high for most efficacy outcomes. Conclusions: The network meta-analysis suggests that Stillen® is non-inferior to rebamipide in improving erosions in patients with acute or chronic gastritis.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 443
Erratum: Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and Adolescents
Shin S, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):443-443. https://doi.org/10.4168/aair.2024.16.4.443
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 443
Open AccessErratum: Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and Adolescents
Shin S, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):443-443. https://doi.org/10.4168/aair.2024.16.4.443
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (3) , 300-307
Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and Adolescents
Shin S, et al. Allergy Asthma Immunol Res. 2024 May;16(3):300-307. https://doi.org/10.4168/aair.2024.16.3.300
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (3) , 300-307
Open AccessPrevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and Adolescents
Shin S, et al. Allergy Asthma Immunol Res. 2024 May;16(3):300-307. https://doi.org/10.4168/aair.2024.16.3.300
- Open Access
- 28 July 2022
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 36 (3) , 173-179
First and second kidney transplantations from living donors offer comparable outcomes for patients
Namkee Oh, Min Jung Kim, Kyo Won Lee, Hyun Cho, Sook Young Woo, Jinsoo Rhu, Seunghwan Lee, Jong Man Kim, Gyu-Seong Choi, Jae Berm Park, Jae-Won Joh. Korean J Transplant 2022;36:173-9. https://doi.org/10.4285/kjt.22.0018
- 28 July 2022
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 36 (3) , 173-179
Open AccessFirst and second kidney transplantations from living donors offer comparable outcomes for patients
Namkee Oh, Min Jung Kim, Kyo Won Lee, Hyun Cho, Sook Young Woo, Jinsoo Rhu, Seunghwan Lee, Jong Man Kim, Gyu-Seong Choi, Jae Berm Park, Jae-Won Joh. Korean J Transplant 2022;36:173-9. https://doi.org/10.4285/kjt.22.0018
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (10) , e71
Influenza Vaccine Effectiveness in Children at the Emergency Department during the 2018-2019 Season: the First Season School-aged Children Were Included in the Korean Influenza National Immunization Program
Yoon Y, et al. J Korean Med Sci. 2021 Feb;36(10):e71. https://doi.org/10.3346/jkms.2021.36.e71
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (10) , e71
Open AccessInfluenza Vaccine Effectiveness in Children at the Emergency Department during the 2018-2019 Season: the First Season School-aged Children Were Included in the Korean Influenza National Immunization Program
Yoon Y, et al. J Korean Med Sci. 2021 Feb;36(10):e71. https://doi.org/10.3346/jkms.2021.36.e71
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Wearable plasma-pads for healthcare applications: Plasma patch, plasma bandage, plasma socks, and plasma cap
Summary form only given. Wearable plasma-devices involving a dielectric barrier discharge (DBD) are introduced. The conventional devices of the atmospheric pressure plasmas, a DBD and a plasma jet developed last decades, have an inconvenient for some cases requiring a frequent treatment, a long period therapy, and a significantly large area to be exposed with the plasma. The wearable plasma-pads are provided to cover such purposes of an user's description. The flexible plasma-pads are comprised by three-layers: a gauzy cloth at the base, a DBD-plasma texture-layer at the middle, and an antiseptic gauze at the top. The DBD-plasma is generated at the space between the bottom cloth and the top gauze. Many kinds of reactive species including UV penetrate through the gauzy-nets into a skin for therapy. We have two ways of texturing the plasma layer: One is to lay the insulated high voltage-wires which are widely used in the electricity. The other is to use the thin polymer-films of a polyimide film (capton film) or a poly-glass film on which the electrodes are made by pasting or printing the conducting materials. In both cases of a plasma layering a high voltage electrode and a ground electrode are formed by many ways of shapes and structures to generate the uniform plasma on the texture surface. The electric power system is also made to be wearable and portable by a rechargeable battery used in a mobile cellular phone. The high voltage is applied with a frequency of several tens of kHz, a sinusoidal voltage of a few kV in rms value through a DC-AC inverter. The plasma pads provide a various forms of products for the user's purpose: such as plasma patch, plasma bandage, plasma socks, and plasma cap, etc. We have made a various size of a plasma patch of which an adhesive tape is attached around the margin. The plasma patch can stick on the face or the skin of a body like a sticking plaster for dermatology. The plasma laced-bandage is applied to a wound and a skin burn with an accident at the scene for stop bleeding and a blood coagulation to prevent the infection. The socks are worn in the night time for the treatment of a tenea-pedis. The cap is for the hair depilation and hair rejuvenation. We introduce the plasma devices relating the basic structures, the electrical properties, and the spectroscopic analysis.
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Wearable plasma-pads for healthcare applications: Plasma patch, plasma bandage, plasma socks, and plasma cap
Summary form only given. Wearable plasma-devices involving a dielectric barrier discharge (DBD) are introduced. The conventional devices of the atmospheric pressure plasmas, a DBD and a plasma jet developed last decades, have an inconvenient for some cases requiring a frequent treatment, a long period therapy, and a significantly large area to be exposed with the plasma. The wearable plasma-pads are provided to cover such purposes of an user's description. The flexible plasma-pads are comprised by three-layers: a gauzy cloth at the base, a DBD-plasma texture-layer at the middle, and an antiseptic gauze at the top. The DBD-plasma is generated at the space between the bottom cloth and the top gauze. Many kinds of reactive species including UV penetrate through the gauzy-nets into a skin for therapy. We have two ways of texturing the plasma layer: One is to lay the insulated high voltage-wires which are widely used in the electricity. The other is to use the thin polymer-films of a polyimide film (capton film) or a poly-glass film on which the electrodes are made by pasting or printing the conducting materials. In both cases of a plasma layering a high voltage electrode and a ground electrode are formed by many ways of shapes and structures to generate the uniform plasma on the texture surface. The electric power system is also made to be wearable and portable by a rechargeable battery used in a mobile cellular phone. The high voltage is applied with a frequency of several tens of kHz, a sinusoidal voltage of a few kV in rms value through a DC-AC inverter. The plasma pads provide a various forms of products for the user's purpose: such as plasma patch, plasma bandage, plasma socks, and plasma cap, etc. We have made a various size of a plasma patch of which an adhesive tape is attached around the margin. The plasma patch can stick on the face or the skin of a body like a sticking plaster for dermatology. The plasma laced-bandage is applied to a wound and a skin burn with an accident at the scene for stop bleeding and a blood coagulation to prevent the infection. The socks are worn in the night time for the treatment of a tenea-pedis. The cap is for the hair depilation and hair rejuvenation. We introduce the plasma devices relating the basic structures, the electrical properties, and the spectroscopic analysis.
- Open Access
- 1 January 2008
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 49 (1) , 37-45
Predictors of Self-Reported Depression in Korean Children 9 to 12 Years of Age
Shin YM, et al. Yonsei Med J. 2008 Feb;49(1):37-45. https://doi.org/10.3349/ymj.2008.49.1.37
- 1 January 2008
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 49 (1) , 37-45
Open AccessPredictors of Self-Reported Depression in Korean Children 9 to 12 Years of Age
Shin YM, et al. Yonsei Med J. 2008 Feb;49(1):37-45. https://doi.org/10.3349/ymj.2008.49.1.37
- 1 September 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 541-544
LTCC Front-end Modules for Multi-band Applications
This paper presents LTCC front-end modules for multi-band applications. A dual-band module composed of a diplexer, a CDMA SAW duplexer, and a GPS SAW filter for CDMA/GPS applications and a tri-band module employing PIN diodes for CDMA/GPS/PCS applications are implemented based on LTCC substrates. The measured results of the dual-band module show that the insertion loss is less than 2.4 dB and 3.5 dB in CDMA Tx and Rx bands, respectively. The insertion of GPS path is about 1.8 dB. The tri-band module provides an insertion loss of less than 0.8 dB and 1.1 dB in CDMA and PCS bands, respectively. The insertion of GPS path is about 0.4 dB. The overall size of both modules is only 4.5 mm times 3.2 mm
- 1 September 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 541-544
LTCC Front-end Modules for Multi-band Applications
This paper presents LTCC front-end modules for multi-band applications. A dual-band module composed of a diplexer, a CDMA SAW duplexer, and a GPS SAW filter for CDMA/GPS applications and a tri-band module employing PIN diodes for CDMA/GPS/PCS applications are implemented based on LTCC substrates. The measured results of the dual-band module show that the insertion loss is less than 2.4 dB and 3.5 dB in CDMA Tx and Rx bands, respectively. The insertion of GPS path is about 1.8 dB. The tri-band module provides an insertion loss of less than 0.8 dB and 1.1 dB in CDMA and PCS bands, respectively. The insertion of GPS path is about 0.4 dB. The overall size of both modules is only 4.5 mm times 3.2 mm